Antidepressant-like effect induced by P2X7 receptor blockade in FSL rats is associated with BDNF signalling activation
Abstract
Background: P2X7 receptors (P2X7R) are ligand-gated ion channels activated by adenosine 5’-triphosphate (ATP), which are involved in processes that are dysfunctional in stress response and depression, such as neurotransmitter release, and neuroimmune response. Genetic and pharmacological inhibition of the P2X7R induce antidepressant-like effects in animals exposed to stress. However, the effect of P2X7R antagonism in an animal model of depression based on selective breeding has not previously been studied, and the mechanism underling the antidepressant-like effect induced by the P2X7R blockade remains unknown. Aims: The present study aimed to: (1) determine whether P2X7R blockade induces antidepressant-like effects in the Flinders Sensitive Line (FSL) rats and, (2) investigate whether brain-derived neurotrophic factor (BDNF) signalling in the frontal cortex and hippocampus is involved in this effect. Methods: FSL and the control Flinders Resistant Line (FRL) rats were treated with vehicle or the P2X7R antagonist A-804598 (3, 10 or 30 mg/Kg/day) for 1 or 7 days before being exposed to the forced swim test (FST). After the behavioural test, animals were decapitated, their brains were removed and the frontal cortex, ventral and dorsal hippocampus were dissected for BDNF signalling analysis. Results: We found that repeated treatment with A-804598 (30 mg/Kg) reduced the immobility time in the FST and activated the BDNF signalling in the ventral hippocampus of FSL rats. Conclusions: P2X7R blockade induces an antidepressant-like effect associated with increased levels of BDNF-AKT-p70 S6 kinase in the ventral hippocampus, which may be mediated by tropomyosin-related kinase B (TRKB) receptor activation supporting the notion of P2X7R antagonism as a potential new antidepressant strategy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Treatment with a selective P2X7 receptor antagonist (A-804598) induced antidepressant-like effect associated with inflammasome stimulation and BDNF signaling activation in rodent hippocampus.
“Moreover, the treatment with a selective P2X7 receptor antagonist (A-804598) induced antidepressant-like effect associated with inflammasome stimulation [147] and BDNF signaling activation [148] in rodent hippocampus.”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [148]
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541 · see citing works
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works
On the Dependency of Cellular Protein Levels on mRNA Abundance
Liu, Y., Beyer, A., & Aebersold, R. (2016) · Cell · doi:10.1016/j.cell.2016.03.014 · Cited by 3,221 · see citing works
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138 · see citing works
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · see citing works
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · see citing works
Comparing protein abundance and mRNA expression levels on a genomic scale
Greenbaum, D. (2003) · Genome biology · doi:10.1186/gb-2003-4-9-117 · Cited by 1,692 · see citing works
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674 · see citing works
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · see citing works
Scaling-up treatment of depression and anxiety: a global return on investment analysis
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P., & Saxena, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30024-4 · Cited by 1,451 · see citing works
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267 · see citing works
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · see citing works
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164 · see citing works
Castrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864 · see citing works
Phosphorylation and Activation of p70 <sup>s6k</sup> by PDK1
Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., & Thomas, G. (1998) · Science · doi:10.1126/science.279.5351.707 · Cited by 826 · see citing works
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800 · see citing works
Interaction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793 · see citing works
A simple role for BDNF in learning and memory?
Cunha, C. (2010) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.001.2010 · Cited by 778 · see citing works
The RSK family of kinases: emerging roles in cellular signalling
Anjum, R., & Blenis, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2509 · Cited by 777 · see citing works
Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714 · see citing works
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · see citing works
How do antidepressants work? New perspectives for refining future treatment approaches
Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30015-9 · Cited by 616 · see citing works
Alessi, D. R., Kozlowski, M. T., Weng, Q.-P., MORRICE, N. A., & Avruch, J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70037-5 · Cited by 574 · see citing works
Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression
Russo-Neustadt, A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00059-7 · Cited by 411 · see citing works
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390 · see citing works
Iwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387 · see citing works
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385 · see citing works
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Costa-Mattioli, M., & Monteggia, L. M. (2013) · Nature Neuroscience · doi:10.1038/nn.3546 · Cited by 367 · see citing works
Dwivedi, Y., Rizavi, H. S., Roberts, R. C., Conley, R. C., Tamminga, C. A., & Pandey, G. N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00300.x · Cited by 333 · see citing works
Ferrari, A. J., Charlson, F. J., Norman, R. E., Flaxman, A. D., Patten, S. B., Vos, T., & Whiteford, H. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069637 · Cited by 330 · see citing works
Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305 · see citing works
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
Donnelly‐Roberts, D. L., Namovic, M. T., Han, P., & Jarvis, M. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00233.x · Cited by 271 · see citing works
Sperlágh, B., Köfalvi, A., Deuchars, J., Atkinson, L., J. Milligan, C., Buckley, N. J., & Vizi, E. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00920.x · Cited by 264 · see citing works
Reanalysis of P2X<sub>7</sub>Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264 · see citing works
The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments
Machado-Vieira, R., Baumann, J., Wheeler-Castillo, C., Latov, D., Henter, I. D., Salvadore, G., & Zarate, C. A. (2010) · Pharmaceuticals · doi:10.3390/ph3010019 · Cited by 263 · see citing works
Bi-phasic change in BDNF gene expression following antidepressant drug treatment
Coppell, A., Pei, Q., & Zetterström, T. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00077-7 · Cited by 241 · see citing works
Sluyter, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2017_59 · Cited by 235 · see citing works
The Flinders Sensitive Line Rat Model of Depression—25 Years and Still Producing
Overstreet, D. H., & Wegener, G. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005397 · Cited by 228 · see citing works
Self-citationBasso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224 · see citing works
Upstream open reading frames: Molecular switches in (patho)physiology
Wethmar, K., Smink, J. J., & Leutz, A. (2010) · Bioessays · doi:10.1002/bies.201000037 · Cited by 192 · see citing works
Neuronal P2X7 Receptors Revisited: Do They Really Exist?
Illes, P., Khan, T. M., & Rubini, P. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3103-16.2017 · Cited by 179 · see citing works
Zangen, A., Nakash, R., Overstreet, D. H., & Yadid, G. (2001) · Psychopharmacology · doi:10.1007/s002130100746 · Cited by 177 · see citing works
Saitoh, M., Pullen, N., Brennan, P., Cantrell, D. A., Dennis, P. B., & Thomas, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201745200 · Cited by 177 · see citing works
Overstreet, D. H., Puciłowski, O., Rezvani, A. H., & Janowsky, D. S. (1995) · Psychopharmacology · doi:10.1007/bf02245589 · Cited by 161 · see citing works
Neuronal P2X7 Receptor: Involvement in Neuronal Physiology and Pathology
Miras‐Portugal, M. T., Sebastián‐Serrano, Á., García, L. D. D., & Dı́az-Hernández, M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3104-16.2017 · Cited by 154 · see citing works
Molteni, R., Calabrese, F., Bedogni, F., Tongiorgi, E., Fumagalli, F., Racagni, G., & Andrea Riva, M. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005766 · Cited by 132 · see citing works
Csölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128 · see citing works
Dwivedi, Y., Rizavi, H. S., Conley, R. R., & Pandey, G. N. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001744 · Cited by 123 · see citing works
Inverse Correlation of Brain and Blood BDNF Levels in a Genetic Rat Model of Depression
Elfving, B., Plougmann, P. H., Müller, H. K., Mathé, A. A., Rosenberg, R., & Wegener, G. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990721 · Cited by 119 · see citing works
Self-citationDonnelly‐Roberts, D. L., Namovic, M. T., Surber, B. W., Vaidyanathan, S. X., Perez‐Medrano, A., Wang, Y., Carroll, W. A., & Jarvis, M. F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.012 · Cited by 111 · see citing works
Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.049 · Cited by 108 · see citing works
Csölle, C., Andó, R. D., Kittel, Á., Gölöncsér, F., Baranyi, M., Soproni, K., Zelena, D., Haller, J., Németh, T., Mócsai, A., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001933 · Cited by 108 · see citing works
Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders
Bhattacharya, A., & Jones, D. N. C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.015 · Cited by 105 · see citing works
McManus, C. J., Cheng, Z., & Vogel, C. (2015) · Molecular BioSystems · doi:10.1039/c5mb00310e · Cited by 103 · see citing works
Metzger, M. W., Walser, S. M., Aprile-Garcia, F., Dedic, N., Chen, A., Holsboer, F., ARZT, E. S., Wurst, W., & Deussing, J. M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9546-z · Cited by 92 · see citing works
Regulation of P2X7 receptor expression and function in the brain
Jimenez-Mateos, E. M., Smith, J., Nicke, A., & Engel, T. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.008 · Cited by 79 · see citing works
Müller, H. K., Wegener, G., Popoli, M., & Elfving, B. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.048 · Cited by 78 · see citing works
Self-citationPuciłowski, O., & Overstreet, D. H. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90293-k · Cited by 72 · see citing works
Immobility-reducing effects of antidepressants in a genetic animal model of depression
Schiller, G. D., Puciłowski, O., Wienicke, C., & Overstreet, D. H. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90267-2 · Cited by 70 · see citing works
Pereira, V. S., Casarotto, P. C., Hiroaki-Sato, V. A., Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.01.008 · Cited by 66 · see citing works
Self-citationPsilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat
Jefsen, O. H., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D., Wegener, G., & Müller, H. K. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.15 · Cited by 63 · see citing works
Self-citationPurinergic Signaling and Energy Homeostasis in Psychiatric Disorders
Lindberg, D. M., Shan, D., Ayers-Ringler, J. R., Oliveros, A., Benitez, J. C. A., Prieto, M. L., McCullumsmith, R. E., & Choi, D. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330163724 · Cited by 59 · see citing works
Ma, M., Ren, Q., Zhang, J.-C., & Hashimoto, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.31 · Cited by 55 · see citing works
du Jardin, K. G., Liebenberg, N., Cajina, M., Müller, H. K., Elfving, B., Sanchez, C., & Wegener, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00978 · Cited by 47 · see citing works
Self-citationLiebenberg, N., Joca, S. R. L., & Wegener, G. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.39 · Cited by 45 · see citing works
Self-citationArdalan, M., Wegener, G., Rafati, A. H., & Nyengaard, J. R. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw098 · Cited by 37 · see citing works
Self-citationregenerative-loop potentiation of glutamate synaptic transmission by microglia and astrocytes
Bennett, M. R., Farnell, L., & Gibson, W. G. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.07.024 · Cited by 28 · see citing works
Catanzaro, J. M., Hueston, C. M., Deak, M. M., & Deak, T. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000072 · Cited by 27 · see citing works
Monoamine involvement in the antidepressant-like effect induced by P2 blockade
Diniz, C. R. A. F., Rodrigues, M., Casarotto, P. C., Pereira, V. S., Crestani, C. C., & Joca, S. R. L. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.011 · Cited by 25 · see citing works
Pereira, V. S., Joca, S. R. L., Harvey, B. H., Elfving, B., & Wegener, G. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.25 · Cited by 25 · see citing works
Self-citationAntidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression
Overstreet, D. H., Hlavka, J., Feighner, J. P., Nicolau, G., & Freed, J. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1815-9 · Cited by 20 · see citing works
Nava, N., Treccani, G., Müller, H. K., Popoli, M., Wegener, G., & Elfving, B. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.11.010 · Cited by 15 · see citing works
Self-citationPurinergic modulation of glutamate transmission: An expanding role in stress-linked neuropathology
Mayhew, J., Graham, B. A., Biber, K. P. H., Nilsson, M., & Walker, F. R. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.023 · Cited by 13 · see citing works
The Global Crisis of Depression: the low of the 21st century?
Caan, W. (2015) · Perspectives in Public Health · doi:10.1177/1757913915569958 · Cited by 9 · see citing works
Pereira, V. S., Suavinha, A. C. D. R., Wegener, G., & Joca, S. R. L. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.39 · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The P2X7 Receptor: Central Hub of Brain Diseases
Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162 · see citing works
Self-citationHyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
Self-citationFudalej, E., Justyniarska, M., Kasarełło, K., Dziedziak, J., Szaflik, J. P., & Cudnoch‐Jędrzejewska, A. (2021) · Ophthalmic Research · doi:10.1159/000514441 · Cited by 112 · see citing works
Purinergic signaling: a potential therapeutic target for depression and chronic pain
Zou, Y., Yang, R., Li, L., Xu, X., & Liang, S. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09801-x · Cited by 49 · see citing works
P2X7R antagonists in chronic stress-based depression models: a review
von Mücke-Heim, I.-A., Ries, C., Urbina-Treviño, L., & Deussing, J. M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01306-3 · Cited by 46 · see citing works
Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
Silote, G. P., Gatto, M. C., Eskelund, A., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2021) · Pharmaceuticals · doi:10.3390/ph14121269 · Cited by 38 · see citing works
Self-citationLei, L., Wang, Y., Chen, C.-Y., Wang, Y., & Zhang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122988 · Cited by 37 · see citing works
Fan, Y., Luan, X., Wang, X., Li, H., Zhao, H., Li, S., Li, X., & Qiu, Z. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111143 · Cited by 35 · see citing works
Brain immune cells characterization in UCMS exposed P2X7 knock-out mouse
Troubat, R., Leman, S., Pinchaud, K., Surget, A., Barone, P. R., Roger, S., Guisquet, A. L., Brizard, B., Belzung, C., & Camus, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.012 · Cited by 33 · see citing works
Sun, H. J., Xin, Y., Wu, J., ShuQin, Z., GuiLian, Z., Wu, H., Zhen, G., HongWei, R., & Yongnan, L. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104773 · Cited by 27 · see citing works
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
Gil, B., Smith, J., Tang, Y., Illés, P., & Engel, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042380 · Cited by 26 · see citing works
Purinergic P2X7 receptor as a potential therapeutic target in depression
Wang, Q., Jin, X., & Guan, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115959 · Cited by 22 · see citing works
Ribeiro, D. E., Casarotto, P. C., Staquini, L., Pinto e Silva, M. A., Biojone, C., Wegener, G., & Joca, S. (2019) · PeerJ · doi:10.7717/peerj.7834 · Cited by 21 · see citing works
Self-citationPurinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
Ribeiro, D. E., Petiz, L. L., Glaser, T., Oliveira‐Giacomelli, Á., Andrejew, R., Saab, F. D. A. R., Milanis, M. D. S., Campos, H. C., Arnaud-Sampaio, V. F., de Oliveira, S. L. B., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109371 · Cited by 20 · see citing works
Self-citationLei, C., Li, N., Chen, J., & Wang, Q. (2023) · Molecules · doi:10.3390/molecules28093859 · Cited by 23 · see citing works
Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions
Sun, B.-X., Peng, A., Liu, P., Wang, M., Ding, H., Hu, Y., & Kang, L. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09879-x · Cited by 19 · see citing works
The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside
von Mücke-Heim, I.-A., & Deussing, J. M. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109366 · Cited by 18 · see citing works
The role of microglia in chronic pain and depression: innocent bystander or culprit?
Yin, N., Yan, E., Duan, W., Mao, C., Qin, F., Yang, C., Hu, Y., & Xu, X. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05780-4 · Cited by 18 · see citing works
Lopresti, B. J., Royse, S. K., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15615 · Cited by 16 · see citing works
Cao, Y., Yin, X., Wu, L., Huang, D., Wang, Z., Wu, F., Jiang, J., Chen, G., & Wang, Q. (2025) · Advanced Materials · doi:10.1002/adma.202500623 · Cited by 12 · see citing works
P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1β
Gölöncsér, F., Baranyi, M., Tod, P., Maácz, F., & Sperlágh, B. (2024) · iScience · doi:10.1016/j.isci.2024.109284 · Cited by 9 · see citing works
Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders
Royse, S. K., Lopresti, B. J., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15657 · Cited by 10 · see citing works
Domingos, L. B., Müller, H. K., da Silva, N. R., Filiou, M. D., Nielsen, A. L., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109870 · Cited by 10 · see citing works
Self-citationBahari, G., Tabasi, F., Hashemi, M. M., Zakeri, Z., & Taheri, M. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05645-3 · Cited by 10 · see citing works
The P2X7 receptor in depression: Novel insights and therapeutic implications
Zhong, Y.-T., Pi, C., Zuo, Y., Yan, W., Li, W., Jiang, Y., Lei, T., Zheng, W., Jiang, J., Yang, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107011 · Cited by 9 · see citing works
Ren, X.-Y., Rubini, P., Engel, T., Tang, Y., & Illés, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107989 · Cited by 9 · see citing works
Zhang, Z., Wang, T., Luo, Z., Zaib, M. H., Yi, M., Zeng, H., Li, P., Tang, D., Verkhratsky, A., & Nie, H. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09979-2 · Cited by 9 · see citing works
Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression
Sikka, P., Behl, T., Chandel, P., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Alhazmi, H. A., & Meraya, A. M. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00550-2 · Cited by 7 · see citing works
Microglia in the pathogenesis of depression, insomnia and their comorbidity
Liu, F., Guo, D., Gao, T., Diao, M., & Han, Y. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100030 · Cited by 8 · see citing works
Olivier, N., Harvey, B. H., Gobec, S., Shahid, M., Košak, U., Žakelj, S., & Brink, C. (2025) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2025.118093 · Cited by 7 · see citing works
Sahafi, O. H., Rezayof, A., Ghasemzadeh, Z., Alijanpour, S., & Rahimian, S. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148058 · Cited by 7 · see citing works
Steyn, S. F. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70058 · Cited by 6 · see citing works
Iring-Varga, B., Baranyi, M., Gölöncsér, F., Tod, P., & Sperlágh, B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1241406 · Cited by 4 · see citing works
von Mücke-Heim, I.-A., Oldekamp, J., Metzger, M. W., Kläffgen, S., Tang, H., Walser, S. M., Dedic, N., Rammes, G., Holsboer, F., Wurst, W., et al. (2025) · Purinergic Signalling · doi:10.1007/s11302-025-10074-x · Cited by 4 · see citing works
Advances in how the peripheral immune system interacts with the brain in health and disease
Ruiz-Rodríguez, V. M., Cuellar-Santoyo, A. O., & Estrada‐Sánchez, A. M. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.059 · Cited by 4 · see citing works
Purinergic P2X Receptors as Therapeutic Targets
Stokes, L., Bidula, S. M., & Sluyter, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-52197-3_13 · Cited by 2 · see citing works
Defining functional states and roles of microglia in neuropsychiatric disorders
Szydłowska, K., Tivanello, R., & Kaminska, B. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1798151 · Cited by 2 · see citing works
Antidepressants as modulators of P2X7 receptor activity
Vidal, V. N., Teixeira, G. P., Faria, J. V., Oliveira, J. A. D. S., Bello, M. L., Rocha, L., & Faria, R. X. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.042 · Cited by 1 · see citing works
Radioneuromodulation of Nucleus Accumbens for Addiction: The First Animal Study
Sözer, A., Şahin, M. Ç., Sözer, B., Sozer, E., Bayık, P., Tokgöz, N., Emmez, H., Kaymaz, M., & Yaman, M. E. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.09.043 · Cited by 1 · see citing works
Purinergic Signaling in Depression
Ribeiro, D. E., Kaster, M. P., Ulrich, H., Lisboa, S. F. D. S., & Joca, S. R. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-26945-5_7
Self-citationExtracellular ATP in psychiatric disorders
von Mücke-Heim, I.-A., & Deussing, J. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30250-3.00015-1
Yu, Y., Wang, Y., Guo, S., Zhang, J., Bai, Y., Liu, C., Liu, X., Li, X., Jiang, X., Liu, P., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1766813
ATP and major affective disorders: the involvement of P2X receptors in pathophysiology
Mattova, S., Šimko, P., Colzi, E., Štammová, E., Urbanská, N., Grigoroiu‐Serbânescu, M., Coppi, E., & Kisková, T. (2026) · Purinergic Signalling · doi:10.1007/s11302-026-10147-5
Brain-derived neurotrophic factor in diabetes: A promising target for cognitive restoration
Chandak, G., Kumar, B., Kumar, S., Ashique, S., Bhui, U., Pandey, N., Debnath, B., Al-Salem, F. M., Yasmin, S., Brady, M. S. M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116658
- Authors
- Ribeiro, D. E., Müller, H. K., Elfving, B., Eskelund, A., Joca, S. R., & Wegener, G.
- Affiliations
- Universidade de São Paulo (BR)
- Aarhus University (DK)
- Department of Physics and Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto - University of São Paulo, Ribeirão Preto, Brazil
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2019-09-17
- Volume
- 33
- Issue
- 11
- Pages
- 1436-1446
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2974247326
- Cited by
- 45
- References
- 77
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 3 · 2019: 1
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- fundação de amparo à pesquisa do estado de são paulo (2013/01737-7)
- aarhus universitets forskningsfond (eMOOD)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- P2X7 receptor, antidepressant-like effects, depression, Flinders Sensitive Line rats, BDNF signalling, TrkB receptor, ventral hippocampus, frontal cortex, forced swim test, neuroimmune response, stress response
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Depression, Disease Models, Animal, Guanidines, Male, Quinolines, Stress, Psychological, Swimming, Time Factors, Brain-Derived Neurotrophic Factor, Maximum Tolerated Dose, Receptor, trkB, Rats, Receptors, Purinergic P2X7, Purinergic P2X Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review